DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2230992/wall-street-analysts-see-a-30-21-upside-in-arvinas-inc-arvn-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2230992 Feb 23, 2024 - The consensus price target hints at a 30.2% upside potential for Arvinas, Inc. (ARVN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. 0

https://www.zacks.com/stock/news/2233166/wall-street-analysts-see-bitfarms-ltd-bitf-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2233166 Feb 28, 2024 - Based on the average brokerage recommendation (ABR), Bitfarms Ltd. (BITF) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.rttnews.com/story.aspx?Id=3426693 Feb 22, 2024 - FTI Consulting, Inc. (FCN) reported Thursday that its fourth-quarter net income climbed to $81.6 million from last year's $47.5 million. 0

https://www.rttnews.com/story.aspx?Id=3424551 Feb 14, 2024 - The major U.S. index futures are currently pointing to a higher open on Wednesday, with stocks likely to regain ground following the sell-off seen in the previous session. 0

https://www.zacks.com/stock/news/2234548/wall-street-analysts-see-arista-networks-anet-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2234548 Mar 01, 2024 - Based on the average brokerage recommendation (ABR), Arista Networks (ANET) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://seekingalpha.com/news/4077692-novo-nordisk-sees-launching-new-obesity-drugs-before-wegovy-patent-expires?source=feed_sector_healthcare Mar 08, 2024 - Novo Nordisk (NVO) reportedly plans to launch its next-generation obesity drugs, Cagrisema and amycretin, ahead of the expiration of its patent for Wegovy. Read more here. 0

https://seekingalpha.com/news/4077751-stifel-downgrades-alx-oncology-to-hold-sees-evorpacept-as-fully-valued?source=feed_sector_healthcare Mar 08, 2024 - Stifel downgraded ALX Oncology (ALXO) to hold, stating it sees the company’s CD47 blocker drug evorpacept as fully valued for the HER2+ gastric cancer opportunity. Read more here. 0

https://www.entrepreneur.com/growing-a-business/how-dria-murphy-is-transforming-the-wellness-space/470757 Mar 07, 2024 - The founder of Alise Collective and by dria discusses her entrepreneurial journey and why she's so passionate about making people happier and healthier. 0

https://seekingalpha.com/news/4077833-delta-ceo-sees-delay-for-boeing-737-max-10-deliveries-until-2027-bloomberg?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news Mar 10, 2024 - Delta Air Lines expects delays in the delivery of Boeing 737 MAX 10 aircraft to as late as 2027 due to safety reviews, CEO Ed Bastian says. 0

https://www.zacks.com/stock/news/2238228/new-york-community-nycb-cuts-dividend-sees-deposit-outflow?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2238228 Mar 08, 2024 - New York Community (NYCB) slashes the quarterly dividend by 80% to a penny to improve liquidity after witnessing a 5% drop in its deposits since the 2023 end through Mar 5, 2024. 0